Tag: Healthcare news
Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals has announced positive top-line results from its pivotal Phase 3 LUCIDITY trial evaluating avexitide, a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist being...
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine alongside Merck's immunotherapy drug Keytruda in melanoma patients.
The...
New Genomic Study Reveals Origin of DRC’s Ebola Outbreak
A new genomic analysis published in Nature Medicine has identified the cause of the Ebola outbreak sweeping the Democratic Republic of the Congo (DRC):...
Eli Lilly Reports 48% Revenue Growth in Q2 2026 and Raises Full-Year Guidance
Eli Lilly and Company announced its financial results for the second quarter of 2026, delivering worldwide revenue of $23.0 billion,a 48% increase compared with the same...
Mankind Pharma Reports Strong Start to FY27 with 12.9% YoY Revenue Growth to ₹4,031 Crore
Mankind Pharma Ltd. 6 announced its financial results for the first quarter of FY27, delivering robust top-line and bottom-line expansion driven by steady chronic therapy demand,...
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
